CAFs derived exosomes miR-196a make advanced head and neck cancer resistant to CDDP by targeting cyclindependent kinase inhibitor 1B (CDKN1B) and inhibitor of growth family (ING5) [99]. This evidence concerns the gene CDKN1B and head and neck cancer.